SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 28 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,020 | -24.1% | 44,476 | 0.0% | 0.00% | – |
| Q2 2023 | $36,915 | +88.6% | 44,476 | 0.0% | 0.00% | – |
| Q1 2023 | $19,569 | -25.4% | 44,476 | 0.0% | 0.00% | – |
| Q4 2022 | $26,236 | -15.4% | 44,476 | 0.0% | 0.00% | – |
| Q3 2022 | $31,000 | -51.6% | 44,476 | 0.0% | 0.00% | – |
| Q2 2022 | $64,000 | -61.7% | 44,476 | 0.0% | 0.00% | – |
| Q1 2022 | $167,000 | -51.9% | 44,476 | 0.0% | 0.00% | – |
| Q4 2021 | $347,000 | – | 44,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First PREMIER Bank | 652,440 | $946,000 | 0.28% |
| METEORA CAPITAL, LLC | 292,538 | $424,000 | 0.08% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 78,115 | $113,000 | 0.02% |
| SILVER OAK SECURITIES, Inc | 51,941 | $64,000 | 0.01% |
| Shaolin Capital Management LLC | 275,000 | $399,000 | 0.01% |
| Elgethun Capital Management | 13,296 | $18,000 | 0.01% |
| LGL PARTNERS, LLC | 23,000 | $33,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,000 | $122,000 | 0.00% |
| Spectrum Management Group, LLC | 5,030 | $7,000 | 0.00% |
| Veritable, L.P. | 43,551 | $63,000 | 0.00% |